Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $248,054 | $1,686,301 | $1,564,144 | $1,535,505 |
| % Growth | -85.3% | 7.8% | 1.9% | – |
| Cost of Goods Sold | $179,923 | $1,178,083 | $1,094,383 | $1,263,774 |
| Gross Profit | $68,130 | $508,218 | $469,761 | $271,731 |
| % Margin | 27.5% | 30.1% | 30% | 17.7% |
| R&D Expenses | $8,975 | $67,929 | $59,076 | $66,287 |
| G&A Expenses | $0 | -$67,082 | $180,487 | -$257,923 |
| SG&A Expenses | $34,229 | -$91,395 | $229,183 | -$354,108 |
| Sales & Mktg Exp. | $0 | -$24,313 | $48,696 | -$96,185 |
| Other Operating Expenses | $1,450 | $231,930 | $36,998 | $980,130 |
| Operating Expenses | $44,653 | $208,464 | $325,257 | $692,308 |
| Operating Income | $23,477 | $299,753 | $144,504 | -$420,577 |
| % Margin | 9.5% | 17.8% | 9.2% | -27.4% |
| Other Income/Exp. Net | $85,513 | -$689 | -$879 | -$2,027 |
| Pre-Tax Income | $108,991 | $299,064 | $143,625 | -$422,603 |
| Tax Expense | $7,159 | $46,217 | $33,644 | $32,701 |
| Net Income | $89,012 | $217,868 | $165,469 | -$408,285 |
| % Margin | 35.9% | 12.9% | 10.6% | -26.6% |
| EPS | 0.1 | 0.25 | 0.19 | -0.47 |
| % Growth | -60% | 31.6% | 140.4% | – |
| EPS Diluted | 0.1 | 0.25 | 0.19 | -0.47 |
| Weighted Avg Shares Out | 861,026 | 870,888 | 870,888 | 862,007 |
| Weighted Avg Shares Out Dil | 861,026 | 870,888 | 870,888 | 862,007 |
| Supplemental Information | – | – | – | – |
| Interest Income | $28,952 | $0 | $0 | $0 |
| Interest Expense | $1,799 | $16,725 | $31,748 | $24,717 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $110,790 | $309,709 | $187,382 | -$288,345 |
| % Margin | 44.7% | 18.4% | 12% | -18.8% |